Literature DB >> 18045113

Centralized HIV-1 envelope immunogens and neutralizing antibodies.

Feng Gao1, Hua-Xin Liao, Beatrice H Hahn, Norman L Letvin, Bette T Korber, Barton F Haynes.   

Abstract

Centralized HIV-1 genes (consensus, most recent common ancestor and center of the tree) have recently been explored for induction of broadly reactive immune responses to overcome the extraordinary genetic diversity among HIV-1 strains. Although all of these strategies are based on artificial sequences predicted by computer programs, they retain biological function, and use the CCR5 co-receptor for entry into target cells as transmitted HIV-1 Envs. Results from laboratory animals indicate that centralized immunogens are superior to many wild-type immunogens for inducing cross-subtype T and B cell immune responses. Structural modifications have improved the ability of consensus Envs to elicit antibody responses that neutralize a spectrum of HIV-1 Env pseudoviruses. However, the more difficult to neutralize tier 2 Env pseudoviruses are generally not neutralized well by anti-consensus Env antibodies, indicating the need for further modifications, new formulations, or additional strategies to generate antibodies that neutralize a full spectrum of transmitted HIV-1 strains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045113     DOI: 10.2174/157016207782418498

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  13 in total

1.  A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.

Authors:  Christine A Bricault; James M Kovacs; Joseph P Nkolola; Karina Yusim; Elena E Giorgi; Jennifer L Shields; James Perry; Christy L Lavine; Ann Cheung; Katharine Ellingson-Strouss; Cecelia Rademeyer; Glenda E Gray; Carolyn Williamson; Leonidas Stamatatos; Michael S Seaman; Bette T Korber; Bing Chen; Dan H Barouch
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

2.  Methods development for Analysis of Partially Deglycosylated Proteins and Application to an HIV Envelope Protein Vaccine Candidate.

Authors:  Eden P Go; Geetha S Hewawasam; Ben J Ma; Hua-Xin Liao; Barton F Haynes; Heather Desaire
Journal:  Int J Mass Spectrom       Date:  2011-08       Impact factor: 1.986

3.  A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets.

Authors:  Brendan M Giles; Ted M Ross
Journal:  Vaccine       Date:  2011-02-12       Impact factor: 3.641

4.  Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.

Authors:  Eden P Go; Alon Herschhorn; Christopher Gu; Luis Castillo-Menendez; Shijian Zhang; Youdong Mao; Haiyan Chen; Haitao Ding; John K Wakefield; David Hua; Hua-Xin Liao; John C Kappes; Joseph Sodroski; Heather Desaire
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

5.  X4 human immunodeficiency virus type 1 gp120 down-modulates expression and immunogenicity of codelivered antigens.

Authors:  Avi-Hai Hovav; Michael Santosuosso; Maytal Bivas-Benita; Andre Plair; Alex Cheng; Mazal Elnekave; Elda Righi; Tao Chen; Satoshi Kashiwagi; Michael W Panas; Shi-Hua Xiang; Karina Furmanov; Norman L Letvin; Mark C Poznansky
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

6.  Glycosylation site-specific analysis of clade C HIV-1 envelope proteins.

Authors:  Eden P Go; Qing Chang; Hua-Xin Liao; Laura L Sutherland; S Munir Alam; Barton F Haynes; Heather Desaire
Journal:  J Proteome Res       Date:  2009-09       Impact factor: 4.466

Review 7.  Critical issues in mucosal immunity for HIV-1 vaccine development.

Authors:  Barton F Haynes; Robin J Shattock
Journal:  J Allergy Clin Immunol       Date:  2008-05-12       Impact factor: 10.793

8.  DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in China.

Authors:  Mingshun Zhang; Lu Zhang; Chunhua Zhang; Kunxue Hong; Yiming Shao; Zuhu Huang; Shixia Wang; Shan Lu
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

9.  Profile of T cell recognition of HIV type 1 consensus group M Gag and Nef peptides in a clade A1- and D-infected Ugandan population.

Authors:  Jennifer Serwanga; Susan Mugaba; Edward Pimego; Bridget Nanteza; Fred Lyagoba; Susan Nakubulwa; Laura Heath; Rebecca N Nsubuga; Nicaise Ndembi; Frances Gotch; Pontiano Kaleebu
Journal:  AIDS Res Hum Retroviruses       Date:  2011-10-17       Impact factor: 2.205

10.  Rhesus macaques vaccinated with consensus envelopes elicit partially protective immune responses against SHIV SF162p4 challenge.

Authors:  Hermancia S Eugene; Brooke R Pierce-Paul; Jodi K Cragio; Ted M Ross
Journal:  Virol J       Date:  2013-04-02       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.